Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.
View/ Open
Volume
86
DOI
10.1128/IAI.00688-17
Journal
Infect Immun
Issue
Metadata
Show full item recordAbstract
Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic cardiomyopathy. The pathological features include myocardial inflammation and fibrosis. In the Brazil strain-infected CD-1 mouse, which recapitulates many of the features of human infection, we found increased plasma levels of resolvin D1 (RvD1), a specialized proresolving mediator of inflammation, during both the acute and chronic phases of infection (>100 days postinfection) as determined by enzyme-linked immunosorbent assay (ELISA). Additionally, ELISA on lysates of trypomastigotes of both strains Tulahuen and Brazil revealed elevated levels of RvD1 compared with lysates of cultured epimastigotes of T. cruzi, tachyzoites of Toxoplasma gondii, trypomastigotes of Trypanosoma brucei, cultured L6E9 myoblasts, and culture medium containing no cells. Lysates of T. cruzi-infected myoblasts also displayed increased levels of RvD1. Lipid mediator metabolomics confirmed that the trypomastigotes of T. cruzi produced RvD1, RvD5, and RvE2, which have been demonstrated to modulate the host response to bacterial infections. Plasma RvD1 levels may be both host and parasite derived. Since T. cruzi synthesizes specialized proresolving mediators of inflammation, as well as proinflammatory eicosanoids, such as thromboxane A2, one may speculate that by using these lipid mediators to modulate its microenvironment, the parasite is able to survive.
Authors
Colas, RA; Ashton, AW; Mukherjee, S; Dalli, J; Akide-Ndunge, OB; Huang, H; Desruisseaux, MS; Guan, F; Jelicks, LA; Matos Dos Santos, FCollections
Language
Copyright statements
Related items
Showing items related by title, author, creator and subject.
-
Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid
Vik, A; Dalli, J; Hansen, TV (2017-06-01) -
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes.
Shivakoti, R; Dalli, J; Kadam, D; Gaikwad, S; Barthwal, M; Colas, RA; Mazzacuva, F; Lokhande, R; Dharmshale, S; Bharadwaj, R (Elsevier, 2019-11-11)Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize ... -
Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis.
Dalli, J; Colas, RA; Walker, ME; Serhan, CN (2018)Solid-phase extraction coupled with liquid chromatography tandem mass spectrometry provides a robust and sensitive approach for the identification and quantitation of specialized pro-resolving mediators (lipoxins, resolvins, ...